Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...

Recent survey study of 978 cancer patients and their relatives uncovered reasons behind their willingness, or lack thereof, ...

Despite focused efforts to improve the diversity of clinical trials, representation in research into head and neck cancer has become less equitable over the past decade, according to retrospective ...

Alexander I. Spira, MD, PhD, FACP, discusses the next steps in the clinical development of zoldonrasib for patients with KRAS ...

China has 4,804 new drug candidates under development, second only to the US at 5,268, according to data provider PharmCube.

Bone metastases are at the center of advanced prostate cancer care, with over 90% of patients with metastatic prostate cancer expected to have bone involvement. 1 These metastatic ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of ...

People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for ...

Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...